Trial Profile
The efficacy of H. pylori eradication therapy with sitafloxacin-metronidazole-vonaprazan 10 day regimen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2020
Price :
$35
*
At a glance
- Drugs Metronidazole (Primary) ; Sitafloxacin (Primary) ; Vonoprazan (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 19 May 2020 Status changed from recruiting to completed, as per Results published at Gastroenterology in conjunction with the Digestive Disease Week 2020
- 19 May 2020 Results published at Gastroenterology in conjunction with the Digestive Disease Week 2020
- 07 Sep 2017 New trial record